These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22088139)

  • 1. Chemical interactions between an active pharmaceutical ingredient and its counterion in a tromethamine salt under forced degradation conditions.
    Loeser E; Sutton P; Skorodinsky A; Lin M; Yowell G
    Drug Dev Ind Pharm; 2012 Mar; 38(3):357-64. PubMed ID: 22088139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
    Bao Y; Mo X; Xu X; He Y; Xu X; An H
    J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A HILIC method for the analysis of tromethamine as the counter ion in an investigational pharmaceutical salt.
    Guo Y; Huang A
    J Pharm Biomed Anal; 2003 Apr; 31(6):1191-201. PubMed ID: 12667935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion.
    Wu Y; Hwang TL; Algayer K; Xu W; Wang H; Procopio A; DeBusi L; Yang CY; Matuszewska B
    J Pharm Biomed Anal; 2003 Dec; 33(5):999-1015. PubMed ID: 14656591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the influence of counterion on the properties of some amorphous organic salts.
    Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
    Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid state compatibility studies with tablet excipients using non thermal methods.
    Liltorp K; Larsen TG; Willumsen B; Holm R
    J Pharm Biomed Anal; 2011 Jun; 55(3):424-8. PubMed ID: 21411259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH control of nucleophilic/electrophilic oxidation.
    Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
    Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemometrics Approaches in Forced Degradation Studies of Pharmaceutical Drugs.
    Roberto de Alvarenga Junior B; Lajarim Carneiro R
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
    Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA
    Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a stable molecular complex of an API with HCl: a long journey to a conventional salt.
    Peresypkin A; Variankaval N; Ferlita R; Wenslow R; Smitrovich J; Thompson K; Murry J; Crocker L; Mathre D; Wang J; Harmon P; Ellison M; Song S; Makarov A; Helmy R
    J Pharm Sci; 2008 Sep; 97(9):3721-6. PubMed ID: 18240276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case study where pharmaceutical salts were used to address the issue of low in vivo exposure.
    Sigfridsson K; Ulvinge ML; Svensson L; Granath AK
    Drug Dev Ind Pharm; 2019 Feb; 45(2):202-211. PubMed ID: 30256689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.
    Sood J; Sapra B; Bhandari S; Jindal M; Tiwary AK
    Ther Deliv; 2014 Oct; 5(10):1123-42. PubMed ID: 25418270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient.
    Thomas S; Bharti A; Tharpa K; Agarwal A
    J Pharm Biomed Anal; 2012 Feb; 60():86-90. PubMed ID: 22115882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.